Access
To read this story in full you will need to login or make a payment (see right).
Scientific Correspondence
Nature 395, 124-125 (10 September 1998) | doi:10.1038/25867
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Faculty Position in Chromosome and Cell Cycle Research
- OMRF
- Oklahoma City, OK 73104, United States
PhD or Postdoctoral Fellow: DFT Calculations in Materials Science
- KAUST (King Abdullah University of Science and Technology)
- Saudi Arabia
p14ARF links the tumour suppressors RB and p53
Stewart Bates1, Andrew C. Phillips1, Paula A. Clark2, Francesca Stott2, Gordon Peters2, Robert L. Ludwig3 & Karen H. Vousden3
Abstract
Most human cancers show perturbation of growth regulation mediated by the tumour-suppressor proteins retinoblastoma (RB) and p53 (ref. 1), indicating that loss of both pathways is necessary for tumour development. Loss of RB function leads to abnormal proliferation related to the deregulation of the E2F transcription factors, but also results in the activation of p53, which suppresses cell growth. Here we show that E2F-1 directly activates expression of the human tumour-suppressor protein p14ARF (the mouse homologue is called p19ARF), which binds to the MDM2-p53 complex and prevents p53 degradation2,5. These results complete a pathway linking abnormal proliferative signals, such as loss of RB, with the activation of a p53 response, through E2F-1 and p14ARF. They suggest that E2F-1, a protein inherently activated by cell-cycle progression, is part of a fail-safe mechanism to protect against aberrant cell growth.
To read this story in full you will need to login or make a payment (see right).
